BCW-Based Resistance Training for Community-Dwelling Sarcopenia Patients (BCW-RES)
Effects of a Behavior Change Wheel (BCW)-Based Resistance Exercise Program on Community-Dwelling Patients With Sarcopenia: A Randomized Controlled Trial
연구 개요
상세 설명
Sarcopenia is a progressive and generalized skeletal muscle disorder that significantly impairs physical function and quality of life in older adults. While resistance exercise is a well-established countermeasure, poor long-term exercise adherence remains a critical clinical barrier. To address this, the current study utilizes the Behavior Change Wheel (BCW) theory to construct a structured, theory-driven resistance exercise program aimed at enhancing both physiological health and behavioral compliance.
This study employs a randomized, waitlist-controlled trial design to ensure ethical equity, allowing all participants to eventually benefit from the intervention. Eligible community-dwelling older adults with sarcopenia will be randomly assigned to either an experimental group or a waitlist control group. The experimental group will immediately commence a 12-week BCW-based resistance exercise intervention (conducted twice weekly). The waitlist control group will undergo a 3-month observation period with their usual routine, after which they will cross over to receive the identical 12-week exercise program.
To comprehensively evaluate the efficacy of the intervention, primary and secondary outcomes-encompassing structural muscle health, physical performance, psychological indicators (e.g., self-efficacy, quality of life), and patient satisfaction-will be rigorously assessed at baseline, at 3 months, and post-intervention.
연구 유형
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Zhejiang
-
Hangzhou, Zhejiang, 중국
- Tianshui Wulin Sub-district Community Health Service Center
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
Meet the diagnostic criteria for sarcopenia according to the Asian Working Group for Sarcopenia (AWGS) 2025:
Low muscle mass (SMI measured by BIA): For age ≥ 65, Male < 7.0 kg/m², Female < 5.7 kg/m²; For age 50-64, Male < 7.6 kg/m², Female < 5.7 kg/m².
Low muscle strength (Handgrip strength): For age ≥ 65, Male < 28 kg, Female < 18 kg; For age 50-64, Male < 34 kg, Female < 20 kg.
Ability to walk independently without assistive devices.
Clear consciousness and stable medical condition.
Willingness to participate, commit to the exercise protocol, and provide signed informed consent.
Proficiency in using a smartphone.
Exclusion Criteria:
- Presence of metal implants, such as cardiac pacemakers, stents, steel plates, or artificial joints (due to BIA measurement constraints).
Cognitive impairment, epilepsy, other neurological disorders, or severe mental illness that prevents cooperation with the study.
Inability to complete the exercise intervention due to severe cardiovascular or musculoskeletal diseases.
Severe organ dysfunction (e.g., heart failure), organ failure, or active infection.
Inability to maintain adherence or significant missing data (participants who withdraw or are lost to follow-up).
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
간섭 없음: Waitlist Control Group
Participants will maintain their usual routine for the first 3 months.
After the primary endpoint assessment at month 3, they will cross over to receive the identical 12-week resistance exercise program.
|
|
|
실험적: Resistance Training Group
Participants in this group will receive the BCW-based resistance exercise program immediately for 12 weeks (twice weekly).
|
Structured 12-week resistance exercise (RE) program based on the Behavior Change Wheel (BCW) and COM-B model. Theory (BCW): Capability is enhanced via sarcopenia education and face-to-face instruction. Opportunity is facilitated by providing free resistance bands, training venues, and peer demonstrations. Motivation is sustained via a points-based reward system, social commendations, and phone/alarm reminders. Protocol (FITT): Frequency: 2 supervised sessions/week (>=48h apart). Time: 60-min sessions (meditation, warm-up, RE, stretching). Intensity: Progressive loading from 40%-50% up to 70% of 1RM using color-coded bands. Progressions (+5% 1RM) guided by Borg RPE (12-14). Type: Multi-component RE (chest, back, shoulders, glutes, lower body, core) doing 1-2 sets of 10 reps with 60-90s rest. Safety: Vitals (BP, HR) are recorded pre- and post-session. Continuous symptom monitoring prevents adverse events. No fasting exercise permitted. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Skeletal Muscle Mass Index
기간: Baseline, 3 months, and 6 months
|
Skeletal muscle mass will be measured using Bioelectrical Impedance Analysis (BIA).
SMI is calculated as appendicular skeletal muscle mass (ASM) divided by height squared (kg/m²).
|
Baseline, 3 months, and 6 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Handgrip Strength
기간: Baseline, Month 3, and Month 6
|
Measured in kilograms (kg) using an electronic handgrip dynamometer.
Participants stand with arms hanging naturally and squeeze the device with their dominant hand with maximum effort.
The test is performed twice with a 1-minute interval, and the maximum value is recorded.
|
Baseline, Month 3, and Month 6
|
|
6-Meter Gait Speed
기간: Baseline, Month 3, and Month 6
|
Calculated in meters per second (m/s).
Participants walk at a usual pace over a 6-meter distance.
The test is conducted at least twice, and the average value is used to evaluate physical performance.
|
Baseline, Month 3, and Month 6
|
|
Self-Efficacy for Exercise Scale - Chinese Version (SEE-C) Score
기간: Baseline, Month 3, and Month 6
|
Assessed using the 9-item Chinese version of the SEE scale.
Each item is rated from 0 (no confidence) to 10 (total confidence).
The total score is the sum of all items divided by 9. Higher scores indicate higher exercise self-efficacy.
|
Baseline, Month 3, and Month 6
|
|
Exercise Adherence Rate
기간: Month 3 (Experimental Group) and Month 6 (Waitlist Group)
|
Expressed as the ratio of actual exercise sessions attended to the planned sessions.
Good adherence is defined as completing 80% or more of the scheduled sessions over the 12-week intervention period.
|
Month 3 (Experimental Group) and Month 6 (Waitlist Group)
|
|
Sarcopenia Quality of Life (SarQoL) Questionnaire Score
기간: Baseline, Month 3, and Month 6
|
Assessed using the Chinese(Mandarin) version of the Sarcopenia Quality of Life (SarQoL) questionnaire.
It specifically evaluates the quality of life in older adults with sarcopenia across multiple domains.
Scores range from 0 to 100, with higher scores representing better quality of life.
|
Baseline, Month 3, and Month 6
|
|
Participant satisfaction
기간: Month 3 (Experimental Group) and Month 6 (Waitlist Group)
|
The questionnaire will cover four domains, including satisfaction with the exercise program, instructor support, facility conditions, and overall perceived benefit.
Each item will be rated on a 5-point Likert scale (1 = very dissatisfied to 5 = very satisfied), and the mean score will be calculated, with higher scores indicating greater satisfaction.
|
Month 3 (Experimental Group) and Month 6 (Waitlist Group)
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Xuejiao Zhu, PhD, Hangzhou Normal University
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 2026017
- YJSYC202603152 (기타 보조금/기금 번호: Hangzhou Normal University)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .